| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 79.63B | 80.49B | 80.47B | 80.85B | 86.79B | 76.56B |
| Gross Profit | 26.19B | 26.69B | 25.91B | 25.73B | 31.18B | 26.86B |
| EBITDA | 6.61B | 6.64B | 6.58B | 7.32B | 13.91B | 10.97B |
| Net Income | 3.73B | 4.15B | 5.45B | 5.86B | 7.79B | 6.16B |
Balance Sheet | ||||||
| Total Assets | 159.62B | 157.76B | 164.82B | 155.94B | 155.46B | 150.06B |
| Cash, Cash Equivalents and Short-Term Investments | 20.69B | 21.06B | 16.42B | 9.56B | 22.69B | 19.88B |
| Total Debt | 5.81B | 7.54B | 7.57B | 4.29B | 4.56B | 4.48B |
| Total Liabilities | 37.05B | 33.40B | 35.39B | 35.35B | 36.87B | 35.61B |
| Stockholders Equity | 122.57B | 124.36B | 129.42B | 120.58B | 118.58B | 114.45B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.50B | 4.59B | -9.74B | 5.16B | 3.09B |
| Operating Cash Flow | 0.00 | 11.54B | 7.91B | -7.59B | 8.43B | 6.60B |
| Investing Cash Flow | 0.00 | -2.14B | -1.06B | 853.00M | -2.39B | -3.33B |
| Financing Cash Flow | 0.00 | -4.71B | -533.00M | -6.35B | -2.90B | -2.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥215.79B | 8.54 | ― | 2.70% | 10.23% | 8.78% | |
76 Outperform | ¥148.33B | 22.89 | ― | 1.92% | 7.46% | -8.01% | |
72 Outperform | ¥98.46B | 8.23 | 22.46% | 4.06% | -8.93% | 48.98% | |
69 Neutral | ¥4.12T | 12.61 | ― | 3.27% | 4.02% | -41.52% | |
67 Neutral | ¥87.00B | 11.91 | ― | 4.76% | 1.81% | 9.07% | |
67 Neutral | ¥618.05B | 9.47 | 6.07% | 3.69% | 0.48% | 6.92% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |